High-Resolution Genomic Copy Number Profiling of Glioblastoma Multiforme by Single Nucleotide Polymorphism DNA Microarray

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Molecular Cancer Research

• Publication date

  2009-05-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1158/1541-7786.MCR-08-0270PMID 19435819
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• PTEN Loss Does Not Predict for Response to RAD001 (Everolimus) in a Glioblastoma Orthotopic Xenograft Test Panel

  2008cited by this paper
• Comprehensive genomic characterization defines human glioblastoma genes and core pathways

  2008influential reference
• Antitumor Activity of Rapamycin in a Phase I Trial for Patients with Recurrent PTEN-Deficient Glioblastoma

  2008cited by this paper
• Highly sensitive method for genomewide detection of allelic composition in nonpaired, primary tumor specimens by use of affymetrix single-nucleotide-polymorphism genotyping microarrays.

  2007cited by this paper
• Fine deletion mapping of chromosome 2q21-37 shows three preferentially deleted regions in oral cancer.

  2007cited by this paper
• Overexpression of the S-phase kinase-associated protein 2 in thyroid cancer.

  2007cited by this paper
• A dual phosphoinositide-3-kinase alpha/mTOR inhibitor cooperates with blockade of epidermal growth factor receptor in PTEN-mutant glioma.

  2007cited by this paper
• E2F-1, Skp2 and cyclin E oncoproteins are upregulated and directly correlated in high-grade neuroendocrine lung tumors

  2007cited by this paper
• Mutant p53R270H gain of function phenotype in a mouse model for oncogene‐induced mammary carcinogenesis

  2007cited by this paper
• Correlated break at PARK2/FRA6E and loss of AF-6/Afadin protein expression are associated with poor outcome in breast cancer

  2007cited by this paper
• High Skp2 Expression Characterizes High-Risk Neuroblastomas Independent of MYCN Status

  2007cited by this paper
• Identification of novel genomic markers related to progression to glioblastoma through genomic profiling of 25 primary glioma cell lines

  2006cited by this paper
• Simultaneous amplification of HER-2 (ERBB2) and topoisomerase IIalpha (TOP2A) genes--molecular basis for combination chemotherapy in cancer.

  2006cited by this paper
• Genetic or epigenetic silencing of low density lipoprotein receptor‐related protein 1B expression in oral squamous cell carcinoma

  2006cited by this paper
• Abnormal methylation of the common PARK2 and PACRG promoter is associated with downregulation of gene expression in acute lymphoblastic leukemia and chronic myeloid leukemia

  2006influential reference
• Mutant p53 gain of function: reduction of tumor malignancy of human cancer cell lines through abrogation of mutant p53 expression

  2006cited by this paper
• High-resolution global genomic survey of 178 gliomas reveals novel regions of copy number alteration and allelic imbalances.

  2006cited by this paper
• Genomic Profiling Identifies Discrete Deletions Associated with Translocations in Glioblastoma Multiforme

  2006influential reference
• Molecular classification of human gliomas using matrix‐based comparative genomic hybridization

  2005cited by this paper
• Overexpressed Skp2 within 5p amplification detected by array‐based comparative genomic hybridization is associated with poor prognosis of glioblastomas

  2005cited by this paper
• Clinicopathologic significance of loss of heterozygosity on chromosome 1 in cervical cancer.

  2005cited by this paper
• Definition and characterization of a region of 1p36.3 consistently deleted in neuroblastoma

  2005cited by this paper
• A robust algorithm for copy number detection using high-density oligonucleotide single nucleotide polymorphism genotyping arrays.

  2005cited by this paper
• Molecular determinants of the response of glioblastomas to EGFR kinase inhibitors.

  2005cited by this paper
• Tumor-Derived p53 Mutants Induce NF-κB2 Gene Expression

  2005cited by this paper
• Proteasome inhibitor PS-341 causes cell growth arrest and apoptosis in human glioblastoma multiforme (GBM)

  2005cited by this paper
• Tumor-derived p53 mutants induce NF-kappaB2 gene expression.

  2005cited by this paper
• GADD45A and EPB41 as tumor suppressor genes in meningioma pathogenesis.

  2005cited by this paper
• Allelic losses at 1p36 and 19q13 in gliomas: correlation with histologic classification, definition of a 150-kb minimal deleted region on 1p36, and evaluation of CAMTA1 as a candidate tumor suppressor gene.

  2005cited by this paper
• An integrated view of copy number and allelic alterations in the cancer genome using single nucleotide polymorphism arrays.

  2004cited by this paper
• Chromosome imbalances in oligodendroglial tumors detected by comparative genomic hybridization.

  2004cited by this paper
• Genetic Pathways to Glioblastoma

  2004cited by this paper
• Mutant p53 gain of function in two mouse models of Li-Fraumeni syndrome.

  2004cited by this paper
• Gain of function of a p53 hot spot mutation in a mouse model of Li-Fraumeni syndrome.

  2004cited by this paper
• Frequent Silencing of Low Density Lipoprotein Receptor-Related Protein 1B (LRP1B) Expression by Genetic and Epigenetic Mechanisms in Esophageal Squamous Cell Carcinoma

  2004influential reference
• Deregulation of the p14ARF/Mdm2/p53 Pathway and G1/S Transition in Two Glioblastoma Sets

  2004cited by this paper
• Transcriptional activities of mutant p53: When mutations are more than a loss

  2004cited by this paper
• Skp2 Gene Copy Number Aberrations Are Common in Non-Small Cell Lung Carcinoma, and Its Overexpression in Tumors with ras Mutation Is a Poor Prognostic Marker

  2004cited by this paper
• Characterization of FRA6E and its potential role in autosomal recessive juvenile parkinsonism and ovarian cancer

  2003cited by this paper
• Refined mapping of 1q32 amplicons in malignant gliomas confirms MDM4 as the main amplification target

  2003cited by this paper
• Progression of myelodysplastic syndrome: allelic loss on chromosomal arm 1p

  2003cited by this paper
• Alteration of the LRP1B Gene Region Is Associated with High Grade of Urothelial Cancer

  2002cited by this paper
• Mutant epidermal growth factor receptor signaling down-regulates p27 through activation of the phosphatidylinositol 3-kinase/Akt pathway in glioblastomas.

  2002cited by this paper
• Genomic organization of a new candidate tumor suppressor gene, LRP1B.

  2000cited by this paper
• p53 from complexity to simplicity: mutant p53 stabilization, gain‐of‐function, and dominant‐negative effect

  2000cited by this paper
• Chromosome imbalances in familial gliomas detected by comparative genomic hybridization

  2000cited by this paper
• Genetic changes in chromosomes 1p and 17p in thyroid cancer progression

  2000cited by this paper
• Amplification and overexpression of the MDM4 (MDMX) gene from 1q32 in a subset of malignant gliomas without TP53 mutation or MDM2 amplification.

  1999cited by this paper
• SKP2 is required for ubiquitin-mediated degradation of the CDK inhibitor p27

  1999cited by this paper
• Chromosome band 1p36 contains a putative tumor suppressor gene important in the evolution of chronic myelocytic leukemia.

  1998cited by this paper
• PTEN mutations in gliomas and glioneuronal tumors

  1998cited by this paper
• Allelotype analysis in the evolution of chronic myelocytic leukemia.

  1997cited by this paper
• Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers

  1997cited by this paper
• Somatic mutations of PTEN in glioblastoma multiforme.

  1997cited by this paper
• Association of EGFR Gene Amplification and CDKN2 (p16/MTS1) Gene Deletion in Glioblastoma Multiforme

  1997cited by this paper
• PTEN, a Putative Protein Tyrosine Phosphatase Gene Mutated in Human Brain, Breast, and Prostate Cancer

  1997cited by this paper
• CDKN2/p16 or RB alterations occur in the majority of glioblastomas and are inversely correlated.

  1996influential reference
• Replacement of the p16/CDKN2 gene suppresses human glioma cell growth.

  1995cited by this paper
• Loss of P16INK4 expression is frequent in high grade gliomas.

  1995cited by this paper
• 5′ CpG island methylation is associated with transcriptional silencing of the tumour suppressor p16/CDKN2/MTS1 in human cancers

  1995cited by this paper
• The retinoblastoma gene is involved in malignant progression of astrocytomas

  1994cited by this paper
• p53 mutations and MDM-2 amplification in renal cell cancers.

  1994cited by this paper
• CDKN2 (p16/MTS1) gene deletion or CDK4 amplification occurs in the majority of glioblastomas.

  1994influential reference
• Association of epidermal growth factor receptor gene amplification with loss of chromosome 10 in human glioblastoma multiforme.

  1992cited by this paper

• Do Glioma Cells Rewire Neural Circuits through Epigenetic Changes? DNA Methylation Analysis of Genes Involved in Neuron–Glioma Communication in the Human Frontal Cortex

  2025cites this paper
• Marizomib in the therapy of brain tumors—how far did we go and where do we stand?

  2025cites this paper
• LRP1B in cancer: From a mutation landscape to predictive biomarkers for precision oncology.

  2025cites this paper
• Molecular Biomarkers of Glioma

  2025cites this paper
• LRP1B Suppresses Immunotherapy Efficacy in Lung Adenocarcinoma by Preventing Ferroptosis

  2024cites this paper
• Intramedullary Spinal Cord Tumors: Whole-Genome Sequencing to Assist Management and Prognosis

  2024cites this paper
• Biomedical applications of wearable biosensors

  2024cites this paper
• Novel Murine Glioblastoma Models That Reflect the Immunotherapy Resistance Profile of Human Disease.

  2023cites this paper
• Quaking but not parkin is the major tumor suppressor in 6q deleted region in glioblastoma

  2022cites this paper
• NAD+ biosynthesis as a collateral lethality target for precision oncology

  2022cites this paper
• Treatments against Polymorphosal discrepancies in Glioblastoma Multiforme

  2022cites this paper
• Parkin and its molecular associations in gliomas – a systematic review

  2021influential citation
• Angiocentric glioma: A case report and review of the literature.

  2021cites this paper
• Parkin: A targetable linchpin in human malignancies.

  2021cites this paper
• LRP1B: A Giant Lost in Cancer Translation

  2021cites this paper
• Investigating the role of Quaking in antigen uptake and cross-presentation by dendritic cells

  2020cites this paper
• Methylxanthines: Potential Therapeutic Agents for Glioblastoma

  2019cites this paper
• Macro Histone Variants: Emerging Rheostats of Gastrointestinal Cancers

  2019cites this paper
• RADIO-IBAG: RADIOMICS-BASED INTEGRATIVE BAYESIAN ANALYSIS OF MULTIPLATFORM GENOMIC DATA.

  2019cites this paper
• Overexpression of miR-20a promotes the progression of osteosarcoma by directly targeting QKI2

  2019cites this paper
• Adaptive capacities of cancer cells in Glioblastoma

  2018cites this paper
• Detection and benchmarking of somatic mutations in cancer genomes using RNA-seq data

  2018cites this paper
• Bayesian variable selection with graphical structure learning: Applications in integrative genomics

  2018cites this paper
• Prognostic stratification of adult primary glioblastoma multiforme patients based on their tumor gene amplification profiles

  2018cites this paper
• Array comparative genomic hybridization identifies high level of PI3K/Akt/mTOR pathway alterations in anal cancer recurrences

  2018cites this paper
• The miR-17-92 cluster/QKI2/β-catenin axis promotes osteosarcoma progression

  2018cites this paper
• Loss of heterozygosity and uniparental disomy of chromosome region 10q23.3–26.3 in glioblastoma

  2018cites this paper
• Comparable Genomic Copy Number Aberrations Differ across Astrocytoma Malignancy Grades

  2018cites this paper
• BAYESIAN INTEGRATIVE ANALYSIS OF OMICS DATA

  2018cites this paper
• Decreased human leukocyte antigen A*02:01 frequency is associated with risk of glioma and existence of human cytomegalovirus: a case–control study in Northern China

  2017cites this paper
• Resveratrol Impairs Glioma Stem Cells Proliferation and Motility by Modulating the Wnt Signaling Pathway

  2017cites this paper
• Molecular and cellular effects of a novel hydroxamate-based HDAC inhibitor – belinostat – in glioblastoma cell lines: a preliminary report

  2016cites this paper
• Emerging functions of the Quaking RNA‐binding proteins and link to human diseases

  2016cites this paper
• Molecular mechanisms of oncogenesis & precision medicine approaches for pediatric low-grade gliomas

  2016cites this paper
• Chromosome 17p Homodisomy Is Associated With Better Outcome in 1p19q Non-Codeleted and IDH-Mutated Gliomas.

  2016cites this paper
• Characterization and Expression of the Zebrafish qki Paralogs

  2016cites this paper
• World Health Organization grade II–III astrocytomas consist of genetically distinct tumor lineages

  2016cites this paper
• MYB-QKI rearrangements in Angiocentric Glioma drive tumorigenicity through a tripartite mechanism

  2016cites this paper
• A novel literature-based approach to identify genetic and molecular predictors of survival in glioblastoma multiforme: Analysis of 14,678 patients using systematic review and meta-analytical tools.

  2015cites this paper
• Expression Analysis of Genes Involved in the RB/E2F Pathway in Astrocytic Tumors

  2015cites this paper
• Identification of parkin interactions: implications for Parkinson’s disease

  2015cites this paper
• Genomic and Functional Analysis of the E3 Ligase PARK2 in Glioma.

  2015cites this paper
• Phenylbutyrate—a pan-HDAC inhibitor—suppresses proliferation of glioblastoma LN-229 cell line

  2015cites this paper
• Bayesian Variable Selection with Structure Learning: Applications in Integrative Genomics

  2015influential citation
• Innovative fluorescent magnetic albumin microbead-assisted cell labeling and intracellular imaging of glioblastoma cells.

  2014cites this paper
• A cytoplasmic quaking I isoform regulates the hnRNP F/H-dependent alternative splicing pathway in myelinating glia

  2014cites this paper
• The pro-apoptotic activity of Drosophila Rbf1 involves dE2F2-dependent downregulation of diap1 and buffy mRNA

  2014cites this paper
• Identification and characterization of novel drugs for the treatment of pediatric gliomas

  2014cites this paper
• Evolution of the quaking gene

  2014cites this paper
• Oncogenic function and prognostic significance of protein tyrosine phosphatase PRL-1 in hepatocellular carcinoma

  2014cites this paper
• Genomic alterations in familial and sporadic epithelial ovarian carcinomas and their clinical relevance

  2014cites this paper
• Genetic Profiling: Searching for Novel Genetic Aberrations in Glioblastoma

  2013influential citation
• Primary Tumors of the Nervous System

  2013cites this paper
• Subgrouping of gliomas on the basis of genetic profiles

  2013cites this paper
• Bayesian methods for expression-based integration of various types of genomics data

  2013cites this paper
• Frequency of NFKBIA deletions is low in glioblastomas and skewed in glioblastoma neurospheres

  2013cites this paper
• Screening for EGFR Amplifications with a Novel Method and Their Significance for the Outcome of Glioblastoma Patients

  2013cites this paper
• Leveraging Metabolomics to Assess the Next Generation of Temozolomide-based Therapeutic Approaches for Glioblastomas

  2013cites this paper
• An emerging role of PARK2 in cancer

  2013cites this paper
• Distinct Genomic Aberrations between Low-Grade and High-Grade Gliomas of Chinese Patients

  2013cites this paper
• miR-34a functions as a tumor suppressor modulating EGFR in glioblastoma multiforme

  2013cites this paper
• PARK2 and PACRG are commonly downregulated in clear‐cell renal cell carcinoma and are associated with aggressive disease and poor clinical outcome

  2013cites this paper
• Detection of EGFRvIII mutant DNA in the peripheral blood of brain tumor patients

  2013cites this paper
• Preparation and Characterizations of Polyclonal Antibodies Against STAR Protein QKI7b

  2013cites this paper
• The role of QKI-5 in CG4 oligodendrocyte differentiation

  2013cites this paper
• Evaluation of Expression and Function of VEGFR 2 , PDGFRα , PDGFRβ , KIT

  2012cites this paper
• Studying a complex tumor: potential and pitfalls.

  2012cites this paper
• STAR RNA-binding protein Quaking suppresses cancer via stabilization of specific miRNA.

  2012cites this paper
• Comparative Analysis of Methods for Identifying Recurrent Copy Number Alterations in Cancer

  2012cites this paper
• Biomarqueurs d'inactivation de gène collatérale et cibles pour une thérapie anticancéreuse

  2012cites this paper
• Distinct genetic alterations in pediatric glioblastomas

  2012cites this paper
• Identification of novel CHD1-associated collaborative alterations of genomic structure and functional assessment of CHD1 in prostate cancer

  2012cites this paper
• Amplified and Homozygously Deleted Genes in Glioblastoma: Impact on Gene Expression Levels

  2012cites this paper
• Passenger Deletions Generate Therapeutic Vulnerabilities in Cancer

  2012cites this paper
• miR-574-5p negatively regulates Qki6/7 to impact β-catenin/Wnt signalling and the development of colorectal cancer

  2012cites this paper
• Role of Btg2 in the Progression of a PDGF-Induced Oligodendroglioma Model

  2012cites this paper
• Recent advances in the molecular understanding of glioblastoma

  2012influential citation
• Harnessing Information Using Genomic Platforms

  2012cites this paper
• Common Chromosomal Fragile Sites: Breakages and Rearrangements in Somatic and Germline Cells

  2012cites this paper
• Integration of Global Spectral Karyotyping, CGH Arrays, and Expression Arrays Reveals Important Genes in the Pathogenesis of Glioblastoma Multiforme

  2012cites this paper
• Network-Guided Analysis of Genes with Altered Somatic Copy Number and Gene Expression Reveals Pathways Commonly Perturbed in Metastatic Melanoma

  2011cites this paper
• Loss of heterozygosity analysis in malignant gliomas

  2011cites this paper
• Genomic changes in gliomas detected using single nucleotide polymorphism array in formalin-fixed, paraffin-embedded tissue: superior results compared with microsatellite analysis.

  2011cites this paper
• Whole Genome Analysis From Microdissected Tissue Revealed Adult Supratentorial Grade II-III Gliomas Are Divided Into Clinically Relevant Subgroups by Genetic Profile

  2011influential citation
• Cooperativity within and among Pten, p53, and Rb pathways induces high-grade astrocytoma in adult brain.

  2011cites this paper
• QKI-Mediated Alternative Splicing of the Histone Variant MacroH2A1 Regulates Cancer Cell Proliferation

  2011cites this paper
• Detailed characterization of alterations of chromosomes 7, 9, and 10 in glioblastomas as assessed by single-nucleotide polymorphism arrays.

  2011cites this paper
• Renal Cell Carcinoma

  2011cites this paper
• Platelet-derived growth factor receptor alpha overexpression cooperates with ink4a/arf loss to promote gliomagenesis---roles of shp-2 and pi3k pathways

  2011cites this paper
• Glioblastoma Patients: p15 Methylation as a Prognostic Factor

  2011cites this paper
• Genomic profiling of tumor initiating prostatospheres

  2010cites this paper
• STRATEGIES FOR THE IDENTIFICATION OF ALLELES INVOLVED IN HEREDITARY BREAST CANCER

  2010cites this paper
• Uniparental Disomy in Cancer – A New Tool in Molecular Cancer

  2010cites this paper
• Alterações metabólicas e o papel da mitocôndria no processo de tumorigênese de astrocitomas humanos

  2010cites this paper
• The Molecular Characterization of Head and Neck Cancer in Young Patients

  2010cites this paper
• Oncocytic Renal Neoplasms: A Molecular Approach to a Common Diagnostic Challenge

  2010cites this paper
• The future role of personalized medicine in the treatment of glioblastoma multiforme

  2010cites this paper
• Association between Acquired Uniparental Disomy and Homozygous Mutations and HER2/ER/PR Status in Breast Cancer

  2010cites this paper
• Somatic mutations of the Parkinson's disease–associated gene PARK2 in glioblastoma and other human malignancies

  2010cites this paper
• The Star Family Member

  2010cites this paper